Cognition Therapeutics (CGTX) Cash from Investing Activities (2022 - 2024)
Cognition Therapeutics (CGTX) reported Cash from Investing Activities of -$1000.0 for Q4 2024, up 96.67% year-over-year from -$508.47 in Q1 2024, and up 96.67% on a QoQ basis from -$30000.0 in Q4 2023.
Cognition Therapeutics (CGTX) has 3 years of Cash from Investing Activities data on file, last reported at -$1000.0 in Q4 2024.
- Quarterly Cash from Investing Activities rose 96.67% year-over-year to -$1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$89000.0 (up 39.46% YoY) and the FY2025 annual result came in at $9000.0, up 325.0% from the prior year.
- Cash from Investing Activities climbed to -$1000.0 in Q4 2024 per CGTX's latest filing, from -$30000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$1000.0 in Q4 2024 and bottomed at -$134000.0 in Q1 2022.
- The 3-year median for Cash from Investing Activities is -$23000.0 (2022), against an average of -$35444.4.
- The widest annual swing landed in 2023, when Cash from Investing Activities plunged 350.0%; it then surged 96.67% in 2024.
- Tracing CGTX's Cash from Investing Activities over 3 years: stood at -$10000.0 in 2022, then tumbled by 200.0% to -$30000.0 in 2023, then soared by 96.67% to -$1000.0 in 2024.
- Per Business Quant, the three latest CGTX Cash from Investing Activities figures stand at -$1000.0 (Q4 2024), -$30000.0 (Q4 2023), and -$58000.0 (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -428.90 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Jun 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -18,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Mar 31, 2023 | -41,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Dec 31, 2022 | -10,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | -4,000.00 |
| Jun 30, 2022 | -4,000.00 |
| Mar 31, 2022 | -134,000.00 |
| Mar 31, 2022 | -134,000.00 |